

Paxlovid costs $1,400-$1,800 without insurance. Learn how to save with coupons, discount cards, and patient assistance programs in 2026.
If you've been prescribed Paxlovid 150 Mg /100 Mg Dose Pack to treat COVID-19, the price tag can be alarming. A 5-day course of Paxlovid costs approximately $1,400 to $1,800 at retail pharmacies without insurance. That's a steep price for any medication, let alone one you need to start taking right away.
The good news is that most patients don't have to pay the full cash price. Between insurance coverage, manufacturer savings programs, and government assistance, there are several ways to bring your cost down significantly — in many cases to $0. In this guide, we'll walk through every option available in 2026.
Without any insurance or financial assistance, the cash price for Paxlovid 150 Mg /100 Mg Dose Pack ranges from $1,400 to $1,800 depending on the pharmacy. This price covers the complete 5-day treatment course.
There is currently no generic version of Paxlovid available in the United States, so there is no lower-cost generic alternative. Pfizer holds the patent on Nirmatrelvir, and no FDA-approved generic has been introduced for the U.S. market as of early 2026.
Here's what you might expect at different pharmacy types:
Several prescription discount programs may help reduce the cost of Paxlovid. However, because Paxlovid is a high-cost brand-name drug with no generic, discount card savings may be limited compared to what they offer for generic medications.
Pfizer's own savings program is the most valuable discount for commercially insured patients:
Prescription discount cards like GoodRx, SingleCare, and RxSaver may show prices for Paxlovid at various pharmacies. However, discounts on expensive brand-name drugs are typically modest — you might save $50 to $200 off the cash price, which still leaves a significant bill. These cards are most useful if you:
Check Medfinder for pharmacy availability and pricing comparisons.
If you're uninsured, underinsured, or struggling to afford Paxlovid, these programs may provide the medication at no cost:
This is the primary assistance program for patients who cannot afford Paxlovid:
Pfizer's broader patient assistance program can help connect you with additional resources:
These independent organizations maintain databases of patient assistance programs:
If you're on Medicare, Paxlovid is covered under most Part D plans. Key points for 2026:
Medicaid coverage for Paxlovid varies by state, but most state Medicaid programs cover FDA-approved COVID-19 treatments. Copays under Medicaid are typically minimal — often $0 to $3.
Many employer-sponsored health plans cover Paxlovid with standard specialty drug copays. Check with your plan's pharmacy benefit to confirm coverage and copay amount before going to the pharmacy.
Some healthcare facilities — particularly Federally Qualified Health Centers (FQHCs) and certain hospitals — participate in the 340B Drug Pricing Program, which allows them to purchase medications at significantly reduced prices. If you receive care at a 340B-eligible facility, ask whether they can fill your Paxlovid prescription at a reduced cost.
Nobody should skip a life-saving COVID-19 treatment because of cost. While Paxlovid's retail price of $1,400 to $1,800 is high, the vast majority of patients can access the medication for significantly less — and often for free — through insurance, Pfizer's PAXCESS program, or the U.S. Government Patient Assistance Program.
Here's a quick summary of your options:
If you're also having trouble finding Paxlovid in stock, use Medfinder to check real-time pharmacy availability, or read our guide to finding Paxlovid near you. For more about the medication itself, see What Is Paxlovid? Uses, Dosage, and What You Need to Know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.